Results 171 to 180 of about 3,367,821 (256)

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

Leukemia, 2009
M. Rohrbacher, U. Berger, A. Hochhaus, G. Metzgeroth, K. Adam, T. Lahaye, Susanne Saussele, M. Müller, J. Hasford, H. Heimpel, R. Hehlmann   +10 more
semanticscholar   +1 more source

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. [PDF]

Biol Blood Marrow Transplant, 2019
Gupta V, Kosiorek HE, Mead A, Klisovic RB, Galvin JP, Berenzon D, Yacoub A, Viswabandya A, Mesa RA, Goldberg J, Price L, Salama ME, Weinberg RS, Rampal R, Farnoud N, Dueck AC, Mascarenhas JO, Hoffman R.   +17 more
europepmc   +1 more source

Kinase drug discovery approaches in chronic myeloproliferative disorders

Oncogene, 2009
C. Kumar, A. Purandare, FY Lee, M. Lorenzi   +3 more
semanticscholar   +1 more source

Disfiguring Nodular Cephalic Xanthoma Disseminatum: An Exceptional Variant of a Forgotten Entity

Acta Dermato-Venereologica, 2019
Arturo Bonometti, Jessica Gliozzo, Chiara Moltrasio, Filippo Bagnoli, Luigia Venegoni, Emanuela Passoni, Marco Paulli, Emilio Berti   +7 more
doaj   +1 more source

Back to biology: new insights on inheritance in myeloproliferative disorders. [PDF]

Curr Hematol Malig Rep, 2014
Braunstein EM, Moliterno AR.
europepmc   +1 more source

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.

Blood, 2009
G. Piaggio, V. Rosti, M. Corselli, F. Bertolotti, G. Bergamaschi, S. Pozzi, D. Imperiale, Barbara Chiavarina, E. Bonetti, F. Novara, M. Sessarego, L. Villani, A. Garuti, M. Massa, R. Ghio, R. Campanelli, A. Bacigalupo, A. Pecci, G. Viarengo, O. Zuffardi, F. Frassoni, G. Barosi   +21 more
semanticscholar   +1 more source

NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin. [PDF]

Front Pharmacol, 2018
Haissaguerre M, Ferriere A, Clark S, Guzman-Quevedo O, Tabarin A, Cota D.   +5 more
europepmc   +1 more source

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders. [PDF]

Arch Med Sci, 2017
Ozdemirkiran FG, Nalbantoglu S, Gokgoz Z, Payzin BK, Vural F, Cagirgan S, Berdeli A.   +6 more
europepmc   +1 more source

Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]

Hematol Transfus Cell Ther
Freire C, Noboa A, Acosta G, León C, Chiang-Wong H, Buenaño M, Loachamin R, Santana P, Huamán-Garaicoa F.   +8 more
europepmc   +1 more source

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. [PDF]

Curr Hematol Malig Rep
Hanna C, Rizkallah J, Charbel N, Sakkal S, Haddad FG.   +4 more
europepmc   +1 more source